News brief
Researchers at NYU Langone Health have found that a common blood test could potentially predict the risk of developing Alzheimer's disease years before any symptoms appear. The study focused on the neutrophil to lymphocyte ratio (NLR), a measure from a standard blood test, which was linked to a higher chance of dementia. This suggests that monitoring NLR could help identify individuals at risk early, paving the way for timely interventions. The study analyzed data from nearly 400,000 patients and highlighted the potential role of immune cells in Alzheimer's progression.
Key points
- Neutrophils might indicate Alzheimer's risk.
- Higher NLR associated with increased dementia risk.
- Early detection could lead to timely interventions.
Understanding Neutrophils and NLR
Neutrophils are a type of white blood cell that act as first responders to infection and inflammation. The neutrophil to lymphocyte ratio (NLR) is a standard lab value derived from a complete blood count, often used to assess immune health. This research suggests that NLR could also serve as an early indicator for Alzheimer's disease risk.
The study examined NLR data from nearly 400,000 patients, finding a consistent link between higher NLR levels and an increased likelihood of developing Alzheimer's or other forms of dementia. This relationship was observed across different patient groups, indicating the broader applicability of the findings.
Diverse Impacts Across Populations
The analysis revealed variations in risk among different demographic groups. Hispanic patients showed a stronger connection between elevated NLR and dementia risk, though the reasons for this are still unclear. Additionally, women exhibited a higher risk associated with increased NLR levels in both healthcare systems studied.
These differences might reflect genetic factors or social determinants such as disparities in healthcare access. Understanding these nuances is crucial for tailoring preventive strategies and improving outcomes for diverse populations.
Potential Role of Neutrophils in Disease
The findings support the idea that neutrophils might play an active role in Alzheimer's disease progression. While they are essential for fighting infections, neutrophils can also cause tissue damage under certain conditions, which may occur in blood vessels and brain tissue in Alzheimer's patients.
Further research is needed to determine whether neutrophils are merely markers of the disease or actively contribute to its progression. Ongoing studies are combining measures of neutrophil activity with advanced brain imaging and cognitive assessments to explore this potential role more deeply.
Discover more from Neurospan
Subscribe to get the latest posts sent to your email.
